Table 1.
Patient Baseline Characteristics.
| Control | RAGO | p-Value | |
|---|---|---|---|
| N = 16 | N = 16 | ||
| Sex | |||
| Male | 9 (56.25%) | 8 (50.0%) | 0.72 a |
| Female | 7 (43.75%) | 8 (50.0%) | |
| Age, years | 58.0 (16.1) | 59.8 (14.1) | 0.59 † |
| ≥65 | 5 (31.25%) | 6 (37.5%) | 0.71 a |
| Side of stroke | |||
| Left | 6 (37.5%) | 10 (62.5%) | 0.15 a |
| Right | 10 (62.5%) | 6 (37.5%) | |
| Stroke type | |||
| hemorrhagic | 6 (37.5%) | 10 (62.5%) | 0.15 a |
| ischemic | 10 (62.5%) | 6 (37.5%) | |
| Stroke duration, months | 18.9 (26.1) | 19.3 (13.3) | 0.26 † |
| Brunnstrom stage | |||
| Upper extremity | 3.4 (1.21) | 3.7 (1.34) | 0.53 † |
| Lower extremity | 3.5 (0.89) | 3.8 (0.84) | 0.37 † |
| Mobility on level surface | |||
| 0 | 5 (31.25%) | 3 (18.75%) | 0.58 † |
| 5 | 3 (18.75%) | 3 (18.75%) | |
| 10 | 3 (18.75%) | 5 (31.25%) | |
| 15 | 5 (31.25%) | 5 (31.25%) |
RAGO, robot-assisted gait orthosis. Level of impairment was assessed using the Barthel Index for Activities of Daily Living subscale: Mobility on level surfaces. Data representing number (%), or mean (SD); a Chi-square test or Fisher’s exact test. † Mann-Whitney U test.